Exited position

Chase Coleman’s Teladoc Health Inc (TDOC) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Tiger Global Management LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ1 2017Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares4.90MHighest verified quarter-end share count
Quarters reported4Verified quarters with shares above zero
What happened?

Tiger Global Management LLC first reported Teladoc Health Inc in Q1 2017. The reported position was reduced across later filings. The latest verified relationship event shows that Tiger Global Management LLC sold the entire position in Q1 2018, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q1 2018
Sold the entire position−235.56K shares · No shares reported at quarter-end
Q4 2017
Sold 86.9% of the position−1.56M shares · 235.56K shares remained
Filing context

Quarter-end price $34.85 · Estimated holding basis $25.00

Q3 2017
Sold 56.2% of the position−2.30M shares · 1.79M shares remained
Filing context

Quarter-end price $33.15 · Estimated holding basis $25.00

Q2 2017
Sold 16.5% of the position−806.60K shares · 4.09M shares remained
Filing context

Quarter-end price $34.70 · Estimated holding basis $25.00

Q1 2017
New position+4.90M shares · 4.90M shares reported
Filing context

Quarter-end price $25.00 · Estimated holding basis $25.00

Portfolio importance

How important was Teladoc Health Inc in Tiger Global Management LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.1%Q4 2017
Last reported rank#37of 49 reported positions
Peak portfolio weight1.2%Q1 2017
Best historical rank#16Q1 2017
At peak importanceQ1 2017
TDOC
1.2%
Largest holding
19.1%
Cross-investor discovery

Who else owns Teladoc Health Inc?

Also reported by 1 other tracked investor in their latest verified filings.

Ray DalioBridgewater Associates, LP
TDOC0.0% of reported portfolio
Explore Teladoc Health Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$6.282026-09-17

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Tiger Global Management LLC’s Form 13F disclosures, not Chase Coleman’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.